- Home
- HURA vs STHO Comparison
HURA vs STHO Comparison
Compare HURA & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURA
- STHO
- Stock Information
- Founded
- HURA 2009
- STHO N/A
- Country
- HURA United States
- STHO United States
- Employees
- HURA N/A
- STHO N/A
- Industry
- HURA
- STHO Real Estate
- Sector
- HURA
- STHO Real Estate
- Exchange
- HURA Nasdaq
- STHO Nasdaq
- Market Cap
- HURA 103.3M
- STHO 89.7M
- IPO Year
- HURA N/A
- STHO N/A
- Fundamental
- Price
- HURA $2.33
- STHO $8.13
- Analyst Decision
- HURA Strong Buy
- STHO
- Analyst Count
- HURA 2
- STHO 0
- Target Price
- HURA $11.50
- STHO N/A
- AVG Volume (30 Days)
- HURA 475.4K
- STHO 175.5K
- Earning Date
- HURA 08-15-2025
- STHO 08-05-2025
- Dividend Yield
- HURA N/A
- STHO N/A
- EPS Growth
- HURA N/A
- STHO N/A
- EPS
- HURA N/A
- STHO N/A
- Revenue
- HURA N/A
- STHO $113,297,000.00
- Revenue This Year
- HURA N/A
- STHO N/A
- Revenue Next Year
- HURA $69.15
- STHO N/A
- P/E Ratio
- HURA N/A
- STHO N/A
- Revenue Growth
- HURA N/A
- STHO N/A
- 52 Week Low
- HURA $1.80
- STHO $6.06
- 52 Week High
- HURA $10.49
- STHO $14.50
- Technical
- Relative Strength Index (RSI)
- HURA N/A
- STHO 61.33
- Support Level
- HURA N/A
- STHO $7.96
- Resistance Level
- HURA N/A
- STHO $8.23
- Average True Range (ATR)
- HURA 0.00
- STHO 0.25
- MACD
- HURA 0.00
- STHO -0.01
- Stochastic Oscillator
- HURA 0.00
- STHO 84.10
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.